4-butyrolactone has been researched along with Adenoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arts, IC; Hollman, PC; Kampman, E; Kuijsten, A; van't Veer, P | 1 |
| Ikeda, K; Izawa, H; Miyoshi, H; Monden, M; Monden, T; Ohnishi, T; Sekimoto, M; Tomita, N; Tsujie, M; Yamamoto, H | 1 |
| Kawabata, K; Matsunaga, K; Mori, H; Nishikawa, A; Sugie, S; Tanakamaru, Y; Yamada, Y | 1 |
3 other study(ies) available for 4-butyrolactone and Adenoma
| Article | Year |
|---|---|
Plasma enterolignans are associated with lower colorectal adenoma risk.
Topics: 4-Butyrolactone; Adenoma; Case-Control Studies; Chromatography, Liquid; Colorectal Neoplasms; Diet; Female; Humans; Incidence; Lignans; Middle Aged; Netherlands; Odds Ratio; Retrospective Studies; Spectrometry, Mass, Electrospray Ionization; Surveys and Questionnaires | 2006 |
Cdk2/cdc2 expression in colon carcinogenesis and effects of cdk2/cdc2 inhibitor in colon cancer cells.
Topics: 4-Butyrolactone; Adenoma; Antineoplastic Agents; Apoptosis; Carcinoma; CDC2 Protein Kinase; CDC2-CDC28 Kinases; Cell Division; Colonic Neoplasms; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinases; Enzyme Inhibitors; Humans; Protein Serine-Threonine Kinases; Tumor Cells, Cultured | 1998 |
Effects of protocatechuic acid, S-methylmethanethiosulfonate or 5-hydroxy-4-(2-phenyl-(E)ethenyl)-2(5H)-furanone(KYN-54) on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced pulmonary carcinogenesis in mice.
Topics: 4-Butyrolactone; Adenoma; Animals; Anticarcinogenic Agents; Carcinogens; Drug Screening Assays, Antitumor; Female; Hydroxybenzoates; Lung Neoplasms; Methyl Methanesulfonate; Mice; Mice, Inbred A; Nitrosamines; Retinoids | 1999 |